Eventide Asset Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,143,938
| Closed | -$12.8M | – | 171 |
|
|
2023
Q4 | $12.8M | Sell |
1,143,938
-546,362
| -32% | -$6.14M | 0.21% | 111 |
|
|
2023
Q3 | $19.7M | Hold |
1,690,300
| – | – | 0.35% | 85 |
|
|
2023
Q2 | $17M | Hold |
1,690,300
| – | – | 0.29% | 93 |
|
|
2023
Q1 | $12.5M | Hold |
1,690,300
| – | – | 0.23% | 113 |
|
|
2022
Q4 | $13.5M | Hold |
1,690,300
| – | – | 0.27% | 97 |
|
|
2022
Q3 | $5.33M | Hold |
1,690,300
| – | – | 0.1% | 119 |
|
|
2022
Q2 | $6.74M | Hold |
1,690,300
| – | – | 0.14% | 109 |
|
|
2022
Q1 | $8.18M | Buy |
1,690,300
+990,300
| +141% | +$4.79M | 0.13% | 113 |
|
|
2021
Q4 | $6.7M | Buy |
+700,000
| New | +$6.7M | 0.09% | 123 |
|